drugset / Trial / NCT01258920
A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the long-term safety and tolerability of paliperidone palmitate in Japanese patients with schizophrenia. Secondary objectives of this study are to: explore the efficacy on symptoms of schizophrenia and the maintenance of treatment effect; explore the pharmacokinetics of paliperidone palmitate through sparse pharmacokinetic sampling.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | paliperidone palmitate | Unknown | 25 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 75 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 150 mg | Intramuscular |